{"entity":{"type":"insider","cik":"0001724870","url":"/insider/0001724870","json_url":"/insider/0001724870.json","name":"Sandercock Colin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2019-06-10","last":"2020-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Sandercock Colin","source":"filing","n_filings":5,"first_seen":"2019-06-10","last_seen":"2020-08-10"}],"transactions":[{"id":9271226,"accession":"0001209191-20-045921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045921","line_url":"/filing/0001209191-20-045921#line-1","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13374.0,"shares_display":"13,374","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":267480.0,"total_display":"267,480.00","total_whole":"267,480","shares_owned_after":17125.0,"shares_owned_after_display":"17,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-10","scope":"insider"},{"id":3046344,"accession":"0001209191-20-045702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-045702","line_url":"/filing/0001209191-20-045702#line-2","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13274.0,"shares_display":"13,274","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":265480.0,"total_display":"265,480.00","total_whole":"265,480","shares_owned_after":17125.0,"shares_owned_after_display":"17,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2881733,"accession":"0001209191-20-045144","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-045144","line_url":"/filing/0001209191-20-045144#line-4","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201.0,"shares_display":"201","price_per_share":20.05,"price_display":"20.05","price_state":"stated","total_value":4030.05,"total_display":"4,030.05","total_whole":"4,030","shares_owned_after":17125.0,"shares_owned_after_display":"17,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-05","scope":"insider"},{"id":2881727,"accession":"0001209191-20-045144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-045144","line_url":"/filing/0001209191-20-045144#line-2","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6425.0,"shares_display":"6,425","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":128500.0,"total_display":"128,500.00","total_whole":"128,500","shares_owned_after":17125.0,"shares_owned_after_display":"17,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":9271095,"accession":"0001209191-20-012027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-012027","line_url":"/filing/0001209191-20-012027#line-2","is_derivative":false,"issuer_cik":"0001724870","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001724870","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15025.0,"shares_display":"15,025","price_per_share":7.9,"price_display":"7.90","price_state":"stated","total_value":118697.5,"total_display":"118,697.50","total_whole":"118,698","shares_owned_after":17125.0,"shares_owned_after_display":"17,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2020-02-24","scope":"insider"},{"id":8514916,"accession":"0001209191-19-035958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-035958","line_url":"/filing/0001209191-19-035958#line-2","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14938.0,"shares_display":"14,938","price_per_share":7.93,"price_display":"7.93","price_state":"stated","total_value":118458.34,"total_display":"118,458.34","total_whole":"118,458","shares_owned_after":16938.0,"shares_owned_after_display":"16,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-10","scope":"insider"},{"id":9271094,"accession":"0001209191-20-012027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-012027","line_url":"/filing/0001209191-20-012027#line-1","is_derivative":false,"issuer_cik":"0001724870","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001724870","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":7.35,"price_display":"7.35","price_state":"stated","total_value":735.0,"total_display":"735.00","total_whole":"735","shares_owned_after":2100.0,"shares_owned_after_display":"2,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-07","filed_date":"2020-02-24","scope":"insider"},{"id":8514913,"accession":"0001209191-19-035958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-035958","line_url":"/filing/0001209191-19-035958#line-1","is_derivative":false,"issuer_cik":"0001645460","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001645460","owner_cik":"0001724870","owner_name":"Sandercock Colin","owner_display_name":"Sandercock Colin","owner_url":"/insider/0001724870","role":"Officer (SVP, General Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel and Sec","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":14200.0,"total_display":"14,200.00","total_whole":"14,200","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645460","name":"Cue Biopharma, Inc.","url":"/issuer/0001645460","role":"Officer (SVP, General Counsel and Sec)","n_filings":5,"first_seen":"2019-06-10","last_seen":"2020-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724870","retrieved_at":"2026-08-24T09:45:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}